DE69910600D1 - Verwendung von metformin gegen die gewichtszunahme, die mit valproat und andere psychotropische arzneimittel verbunden ist - Google Patents

Verwendung von metformin gegen die gewichtszunahme, die mit valproat und andere psychotropische arzneimittel verbunden ist

Info

Publication number
DE69910600D1
DE69910600D1 DE69910600T DE69910600T DE69910600D1 DE 69910600 D1 DE69910600 D1 DE 69910600D1 DE 69910600 T DE69910600 T DE 69910600T DE 69910600 T DE69910600 T DE 69910600T DE 69910600 D1 DE69910600 D1 DE 69910600D1
Authority
DE
Germany
Prior art keywords
weight gain
valproat
metformin
medicinal products
gain related
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69910600T
Other languages
English (en)
Other versions
DE69910600T2 (de
Inventor
Marie Cottingham
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MORRISON, JOHN A., CINCINNATI, OHIO, US
Original Assignee
COTTINGHAM ELIZABETH M
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by COTTINGHAM ELIZABETH M filed Critical COTTINGHAM ELIZABETH M
Application granted granted Critical
Publication of DE69910600D1 publication Critical patent/DE69910600D1/de
Publication of DE69910600T2 publication Critical patent/DE69910600T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69910600T 1998-10-15 1999-10-15 Verwendung von metformin gegen die gewichtszunahme, die mit valproat und andere psychotropische arzneimittel verbunden ist Expired - Lifetime DE69910600T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US10439498P 1998-10-15 1998-10-15
US104394P 1998-10-15
US09/416,330 US6194466B1 (en) 1998-10-15 1999-10-12 Use of metformin to counteract weight gain associated with valproate and other psychotropic medications
US416330 1999-10-12
PCT/US1999/024262 WO2000021522A1 (en) 1998-10-15 1999-10-15 Use of metformin to counteract weight gain associated with valproate and other psychotropic medications

Publications (2)

Publication Number Publication Date
DE69910600D1 true DE69910600D1 (de) 2003-09-25
DE69910600T2 DE69910600T2 (de) 2004-06-24

Family

ID=26801492

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69910600T Expired - Lifetime DE69910600T2 (de) 1998-10-15 1999-10-15 Verwendung von metformin gegen die gewichtszunahme, die mit valproat und andere psychotropische arzneimittel verbunden ist

Country Status (6)

Country Link
US (1) US6194466B1 (de)
EP (1) EP1121110B1 (de)
AT (1) ATE247462T1 (de)
AU (1) AU6432899A (de)
DE (1) DE69910600T2 (de)
WO (1) WO2000021522A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4167742B2 (ja) * 1998-01-23 2008-10-22 中央発條株式会社 押し引きコントロールケーブル
US20050171088A1 (en) * 2004-01-30 2005-08-04 Astrazeneca Ab Treatment of psychoses with dibenzothiazepine antipsychotic
US20060246131A1 (en) * 2005-04-28 2006-11-02 Cottlingham Elizabeth M Use of metformin to counteract weight gain associated with psychotropic medications
WO2008090534A1 (en) * 2007-01-26 2008-07-31 Berand Limited Methods and compositions for inhibition of excessive weight gain, reduction of inappropriate eating behaviours and inhibition of binge eating for the treatment of obesity
EP3328494A4 (de) * 2015-08-01 2019-04-03 Stephen J. Petti Zusammensetzungen und verfahren zur kombination pharmakologischer behandlungen zur induktion einer verlängerten, milden abnahme der körperkerntemperatur
AU2019321641A1 (en) 2018-08-17 2021-04-15 Frequency Therapeutics, Inc. Compositions and methods for generating hair cells by upregulating Jag-1
WO2020037326A1 (en) * 2018-08-17 2020-02-20 Frequency Therapeutics, Inc. Compositions and methods for generating hair cells by downregulating foxo

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4432757A1 (de) * 1994-09-14 1996-03-21 Boehringer Mannheim Gmbh Pharmazeutische Zubereitung enthaltend Metformin und Verfahren zu deren Herstellung

Also Published As

Publication number Publication date
EP1121110A1 (de) 2001-08-08
DE69910600T2 (de) 2004-06-24
ATE247462T1 (de) 2003-09-15
AU6432899A (en) 2000-05-01
WO2000021522A1 (en) 2000-04-20
US6194466B1 (en) 2001-02-27
EP1121110B1 (de) 2003-08-20

Similar Documents

Publication Publication Date Title
GEP20063799B (en) Tropane derivatives useful in therapy
MY119403A (en) Novel compounds with analgesic effect.
DE69225421T2 (de) Sumatriptan enthaltende Arzneimittel
AU2506388A (en) Azelastine-containing medicaments for application in the nose and/or at the eye
TR199801180T2 (xx) Aneljestik etkiye sahip yeni bile�ikler.
MY132705A (en) Novel compounds with analgesic effect
NO307495B1 (no) Anvendelse av riluzol ved fremstilling av medikamenter for behandling av Parkinsons sykdom og Parkinsonske syndromer
DE69531098D1 (de) Piperidine und pyrrolidine
FI964332A (fi) Eräiden metaanibisfosfonihappojohdannaisten käyttö proteesin löystymisen ja proteesin vaelluksen estämiseen
BG106171A (en) Compositions and uses of et743 for treating cancer
ATE99172T1 (de) Verwendung von acetyl-l-carnitin zur behandlung von katarakt, sowie pharmazeutische zusammensetzungen fuer eine derartige behandlung.
MX9708803A (es) Compuestos biaromaticos de propinilo o dienilo.
DE69200711D1 (de) Pharmazeutische Zusammensetzungen enthaltend Fluticasonpropionat und Oxikonazol oder dessen Salz zur lokalen Anwendung.
DE69910600D1 (de) Verwendung von metformin gegen die gewichtszunahme, die mit valproat und andere psychotropische arzneimittel verbunden ist
NO943288L (no) Anvendelse av pentoksyfyllin ved fremstilling av farmasöytiske preparater til behandling av granulomatöse og fibroserende lungesykdommer
AR026254A1 (es) El uso de una preparacion de liberacion controlada para la preparacion de un medicamento para aumentar la dosis o la exposicion sistemica de un farmaco queinhibe la fosfodiesterasa 4
DE69111974T2 (de) Verwendung von Lithium zur Behandlung oder Prophylaxe von Molluscum contagiusum.
JPS6483020A (en) Medicinal composition for preventing or treating aids
NZ268110A (en) Use of ropivacaine salt in pharmaceutical compositions for the treatment of pain with sensoric block and minimal motor blockage
YU25202A (sh) Supstituisani piroli kao antiproliferativna sredstva za lečenje kancera
SE9101341D0 (sv) New medicinal use
NO20010984D0 (no) Anvendelse av R(+)-<alfa>-(2,3-dimetoksyfenyl)-1-[2-(4- fluorfenyl)etyl]-4-piperidinmetanol for behandling av søvnforstyrrelser
KR890001558A (ko) 공황(恐慌) 장애를 경감시키는 제피론 및 이의 약학적 허용 산부가염
KR920700041A (ko) 치료화합물과 그의 조성 및 용도
ATE334675T1 (de) Arzneimittel enthaltend substituierte 2,5- diaminomethyl-1h-pyrrole

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: MORRISON, JOHN A., CINCINNATI, OHIO, US